Compare ARQT & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARQT | PBF |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | 2020 | 2012 |
| Metric | ARQT | PBF |
|---|---|---|
| Price | $29.51 | $31.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 12 |
| Target Price | $24.83 | ★ $29.83 |
| AVG Volume (30 Days) | ★ 2.3M | 2.2M |
| Earning Date | 10-28-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 3.44% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $317,929,000.00 | ★ $29,544,100,000.00 |
| Revenue This Year | $85.51 | N/A |
| Revenue Next Year | $30.74 | $3.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.21 | N/A |
| 52 Week Low | $11.13 | $13.62 |
| 52 Week High | $31.77 | $41.48 |
| Indicator | ARQT | PBF |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 36.80 |
| Support Level | $28.95 | $31.30 |
| Resistance Level | $31.77 | $34.32 |
| Average True Range (ATR) | 1.36 | 1.68 |
| MACD | -0.14 | -0.64 |
| Stochastic Oscillator | 54.51 | 3.50 |
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.